[1]郭志芹,韩学尧,沈景红.高压氧治疗糖尿病足溃疡的研究进展[J].国际内分泌代谢杂志,2017,37(02):108-111.[doi:10.3760/cma.j.issn.1673-4157.2017.02.010]
　Guo Zhiqin*,Han Xueyao,Shen Jinghong..Hyperbaric oxygen therapy for diabetic foot ulcers[J].International Journal of Endocrinology and Metabolism,2017,37(02):108-111.[doi:10.3760/cma.j.issn.1673-4157.2017.02.010]
点击复制

高压氧治疗糖尿病足溃疡的研究进展()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
37
期数:
2017年02期
页码:
108-111
栏目:
综述
出版日期:
2017-03-20

文章信息/Info

Title:
Hyperbaric oxygen therapy for diabetic foot ulcers
作者:
郭志芹; 韩学尧; 沈景红
030013 太原,山西中医学院中西医结合医院内分泌科(郭志芹); 100035 北京大学人民医院内分泌科(韩学尧); 100043 北京石景山区中医医院内科(沈景红)
Author(s):
Guo Zhiqin*;  Han Xueyao;  Shen Jinghong.
*Department of Endocrinology, Shanxi University of Traditional Chinese Medicine Hospital of Integrated Traditional Chinese and Western Medicine,Taiyuan 030013, China
关键词:
糖尿病足;  高压氧;  治疗
Keywords:
Diabetic foot;  Hyperbaric oxygenation;  Treatment
DOI:
10.3760/cma.j.issn.1673-4157.2017.02.010
摘要:
糖尿病足溃疡是糖尿病并发症之一,若得不到及时正确的治疗,致残、致死率极高。目前临床治疗需要联合多种手段。高压氧治疗可以改善创面组织缺氧、增强灌注、减少水肿、下调炎性细胞因子、促进成纤维细胞增殖和胶原合成、动员血管干细胞并刺激血管生成等,促进溃疡愈合,目前已经成为糖尿病足溃疡治疗的有效辅助治疗方法之一。临床应用时需要严格掌握适应证、禁忌证,使用正确的方法以及适当的疗程,并注意不良反应。
Abstract:
Diabetic foot ulcer is one of the diabetic complications. It will lead to a high rate of disability and mortality if not timely and correctly treated. Current clinical treatment needs a combination of various means. Hyperbaric oxygen therapy can improve tissue hypoxia, enhance perfusion, reduce edema, down-regulate inflammatory cytokines, promote fibroblast proliferation and collagen synthesis, mobilize vascular stem cells and stimulate angiogenesis, so that it can promote ulcer healing. Hyperbaric oxygen therapy has become one of the effective adjuvant therapy to treat diabetic foot ulcer.Clinical application needs to grasp strictly the indications and contraindications, use the correct method and appropriate treatment, and pay attention to the side effects.

参考文献/References:

[1] Leone S, Pascale R, Vitale M,et al. Epidemiology of diabetic foot[J].Infez Med,2012,20(Suppl 1):8-13.
[2] Richard JL, Schuldiner S. Epidemiology of diabetic foot problems[J].Rev Med Interne,2008,29(Suppl 2):S222-S230. DOI:10.1016/S0248-8663(08)73949-3.
[3] Alavi A, Sibbald RG, Mayer D,et al. Diabetic foot ulcers: part Ⅱ. management[J].J Am Acad Dermatol,2014,70(1):21.e1-e24.DOI:10.1016/j.jaad.2013.07.048.
[4] Chen X, Duan XS, Xu LJ,et al. Interleukin-10 mediates the neuroprotection of hyperbaric oxygen therapy against traumatic brain injury in mice[J].Neuroscience,2014,266:235-243. DOI: 10.1016/j.neuroscience.2013.11.036.
[5] Qi Z, Gao CJ, Wang YB,et al. Effects of hyperbaric oxygen preconditioning on ischemia-reperfusion inflammation and skin flap survival[J].Chin Med J(Engl),2013,126(20):3904-3909.
[6] Hui J, Zhang ZJ, Zhang X, et al. Repetitive hyperbaric oxygen treatment attenuates complete Freund's adjuvant-induced pain and reduces glia-mediated neuroinflammation in the spinal cord[J].J Pain,2013,14(7):747-758. DOI: 10.1016/j.jpain.2013.02.003.
[7] Chen S, Xiao N, Zhang X. Effect of combined therapy with ephedrine and hyperbaric oxygen on neonatal hypoxic-ischemic brain injury[J].Neurosci Lett,2009,465(2):171-176. DOI: 10.1016/j.neulet.2009.09.011.
[8] Sun Q, Sun Q, Liu Y,et al. Anti-apoptotic effect of hyperbaric oxygen preconditioning on a rat model of myocardial infarction[J].J Surg Res,2011,171(1):41-46. DOI: 10.1016/j.jss.2010.01.036.
[9] Aydin F, Kaya A, Karapinar L,et al. IGF-1 increases with hyperbaric oxygen therapy and promotes wound healing in diabetic foot ulcers[J].J Diabetes Res,2013,2013:567834. DOI:10.1155/2013/567834.
[10] Nasole E, Nicoletti C, Yang ZJ,et al. Effects of alpha lipoic acid and its R+ enantiomer supplemented to hyperbaric oxygen therapy on interleukin-6, TNF-α and EGF production in chronic leg wound healing[J].J Enzyme Inhib Med Chem,2014,29(2):297-302. DOI:10.3109/14756366.2012.759951.
[11] Yuan LJ, Niu CC, Lin SS,et al. Additive effects of hyperbaric oxygen and platelet-derived growth factor-BB in chondrocyte transplantation via up-regulation expression of platelet-derived growth factor-beta receptor[J].J Orthop Res,2009,27(11):1439-1446. DOI:10.1002/jor.20889.
[12] Thom SR, Milovanova TN, Yang M,et al. Vasculogenic stem cell mobilization and wound recruitment in diabetic patients: increased cell number and intracellular regulatory protein content associated with hyperbaric oxygen therapy[J].Wound Repair Regen,2011,19(2):149-161. DOI:10.1111/j.1524-475X.2010.00660.x.
[13] 马辕华,雷永红,周敏,等.高压氧治疗下肢慢性创面愈合与外周血内皮祖细胞的相关性[J].中华医学杂志,2011,91(45):3214-3218.DOI:10.3760/cma.j.issn.0376-2491.2011.45.013.
[14] 中华医学会高压氧医学分会.医学用高压氧舱管理与应用规范,北京,2015.
[15] Gesell LB. Hyperbaric oxygen therapy indications. 12th ed. Undersea and Hyperbaric Medical Society,2008.
[16] Löndahl M, Katzman P, Nilsson A,et al. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes[J].Diabetes Care,2010,33(5):998-1003. DOI: 10.2337/dc09-1754.
[17] Duzgun AP, Satir HZ, Ozozan O,et al. Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers[J].J Foot Ankle Surg,2008,47(6):515-519. DOI: 10.1053/j.jfas.2008.08.002.
[18] Kalani M, J rneskog G, Naderi N,et al. Hyperbaric oxygen(HBO)therapy in treatment of diabetic foot ulcers. Long-term follow-up[J].J Diabetes Complications,2002,16(2):153-158.
[19] Opasanon S, Pongsapich W, Taweepraditpol S, et al. Clinical effectiveness of hyperbaric oxygen therapy in complex wounds[J].J Am Coll Clin Wound Spec,2015,6(1-2):9-13. DOI: 10.1016/j.jccw.2015.03.003.
[20] Oliveira N, Rosa P, Borges L,et al. Treatment of diabetic foot complications with hyperbaric oxygen therapy: a retrospective experience[J].Foot Ankle Surg,2014,20(2):140-143. DOI: 10.1016/j.fas.2014.02.004.
[21] Margolis DJ, Gupta J, Hoffstad O,et al. Lack of effectiveness of hyperbaric oxygen therapy for the treatment of diabetic foot ulcer and the prevention of amputation: a cohort study[J].Diabetes Care,2013,36(7):1961-1966. DOI: 10.2337/dc12-2160.
[22] Hawkins GC. Comment on: Margolis et al. Lack of effectiveness of hyperbaric oxygen therapy for the treatment of diabetic foot ulcer and the prevention of amputation: a cohort study[J]. Diabetes Care,2013,36(8):e129. DOI:10.2337/dc13-0589.
[23] Fedorko L, Bowen JM, Jones W, et al. Hyperbaric oxygen therapy does not reduce indications for amputation in patients with diabetes with nonhealing ulcers of the lower limb: a prospective, double-blind, randomized controlled clinical trial[J].Diabetes Care,2016,39(3):392-399. DOI: 10.2337/dc15-2001.
[24] Akgül EA, Karakaya J, Aydn S. Role of comorbidities as limiting factors to the effect of hyperbaric oxygen in diabetic foot patients: a retrospective analysis[J].Diabetes Ther,2014,5(2):535-544. DOI: 10.1007/s13300-014-0085-8.

相似文献/References:

[1]褚月颉,王鹏华,李代清,等.糖尿病足患者创面肉芽组织中Angiomotin表达的探讨[J].国际内分泌代谢杂志,2015,(04):226.[doi:10.3760/cma.j.issn.1673-4157.2015.04.003]
　Chu Yuejie*,Wang Penghua,Li Daiqing,et al.Angiomotin expression in wound granulation tissues from patients with diabetic foot[J].International Journal of Endocrinology and Metabolism,2015,(02):226.[doi:10.3760/cma.j.issn.1673-4157.2015.04.003]
[2]惠宗光,周学伟,李文通,等.β3肾上腺素能受体基因多态性与糖尿病足的相关性研究[J].国际内分泌代谢杂志,2014,(02):138.[doi:10.3760/cma.j.issn.1673-4157.2014.02.019]
　Hui Zongguang*,Zhou Xuewei,Li Wentong,et al.Relationship between gene polymorphism of beta 3-adrenergic receptor and diabetic foot[J].International Journal of Endocrinology and Metabolism,2014,(02):138.[doi:10.3760/cma.j.issn.1673-4157.2014.02.019]
[3]王中京 邓艾平 李居怡 徐子辉 吕晓玉 张旭艳 付秀丽 李亚蓉 宋春宇.细胞因子与糖尿病足血管发生的相关性研究[J].国际内分泌代谢杂志,2019,39(02):120.[doi:10.3760/cma.j.issn.1673-4157.2019.02.012]
　Wang Zhongjing,Deng Aiping,Li Juyi,et al.Study on the correlation of cytokines and the angiogenesis of diabetic foot[J].International Journal of Endocrinology and Metabolism,2019,39(02):120.[doi:10.3760/cma.j.issn.1673-4157.2019.02.012]
[4]徐俊,许樟荣.国际糖尿病足工作组《糖尿病足感染诊断与治疗指南 (2019版)》解读[J].国际内分泌代谢杂志,2020,40(06):425.[doi:10.3760/cma.j.cn121383-20200710-07077]
　Xu Jun,Xu Zhangrong.Interpretation of diagnosis and treatment guidelines for diabetic foot infection(2019 Edition)by international Working Group on Diabetic Foot[J].International Journal of Endocrinology and Metabolism,2020,40(02):425.[doi:10.3760/cma.j.cn121383-20200710-07077]
[5]徐俊,许樟荣.国际糖尿病足工作组《糖尿病足溃疡周围动脉病变诊断、预后与管理指南(2019版)》解读[J].国际内分泌代谢杂志,2021,41(02):142.[doi:10.3760/cma.j.cn121383-20210109-01022]
　Xu Jun,Xu Zhangrong..Interpretation of guideline on diagnosis, prognosis and management of peripheral artery disease in patients with a foot ulcer and diabetes(2019 edition)by International Working Group on the Diabetic Foot[J].International Journal of Endocrinology and Metabolism,2021,41(02):142.[doi:10.3760/cma.j.cn121383-20210109-01022]

备注/Memo

备注/Memo:
通信作者:郭志芹,Email: 1409020578@qq.com
更新日期/Last Update: 2017-03-20